I am a sinus specialist trained in the management of patients with HHT epistaxis. While completing a fellowship at Stanford, I published a randomized controlled clinical trial investigating the benefit of local submucosal injection of bevacizumab (Avastin) at the time of bipolar electrocautery in the OR, and demonstrated an improvement in intensity, frequency, and duration of epistaxis up to 6 months after surgery. I appreciate the opportunity to take care of this patient population.
Dr. Locke is a fellowship-trained rhinologist and anterior skull base surgeon. She earned her medical degree at the McGovern Medical School in Houston and completed her residency at the University of Kansas School of Medicine. Following residency, she completed her fellowship in rhinology and anterior skull base surgery at the University of Pennsylvania, also a designated HHT Center of Excellence.
As an otolaryngologist, nosebleeds (epistaxis) are a routine part of my practice. However, I have always been interested in the more challenging cases, and patients with HHT often are some of the most difficult to control. Since becoming interested in this population, I have dedicated time to researching various techniques and have several options for managing these troublesome nosebleeds. It is rewarding to be able to provide some relief in the severity of these bleeds.
Dr. Ryan Little is a board-certified, fellowship-trained rhinologist with experience in the diagnosis, treatment, and management of problems involving the nose and sinuses. As a rhinologist practicing in an academic setting, Dr.
